You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

response prediction

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Rome (Tumor biopsy)

Recruiting
  • Ovarian Cancer
  • Tumor biopsy
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 2, 2023

Hemophagocytic Lymphohistiocytoses, EBV, Metabonomics Trial in Beijing (observational)

Not yet recruiting
  • Hemophagocytic Lymphohistiocytoses
  • +2 more
  • observational
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Dec 22, 2022

Hepatocellular Carcinoma, Atezolizumab-bevacizumab, Response Evaluation Trial in Seoul (Early response evaluation)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Early response evaluation
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Feb 28, 2023

Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal

Recruiting
  • Gastric Cancer
  • +2 more
  • Establishment of organoid cultures and in vitro sensitivity testing
  • Dresden, Germany
  • +1 more
Jan 11, 2023

Migraine, Head Pain Trial in Valladolid (Candesartan)

Recruiting
  • Migraine
  • Head Pain
  • Valladolid, Spain
    Hospital Clínico Universitario Valladolid
Feb 9, 2022

Neoadjuvant Therapy in Gastric and Gastroesophageal Cancer

Completed
  • Patients With Locally Advanced Carcinoma of the Stomach and Oesophagogastric Junction
  • CT scan
  • (no location specified)
Sep 13, 2023

Metastatic Breast Cancer, Recurrent Ovarian Carcinoma Trial in Salt Lake City, Fairfax (Ribociclib, Belinostat)

Recruiting
  • Metastatic Breast Cancer
  • Recurrent Ovarian Carcinoma
  • Salt Lake City, Utah
  • +1 more
May 3, 2022

Anlotinib Treatment Response Using Contrast Enhanced Ultrasound

Recruiting
  • Pheochromocytoma, Metastatic
  • +3 more
  • Contrast-enhanced ultrasound(CEUS)
  • Beijing, China
    Peking Union Medical College Hospital
Aug 28, 2023

Cell-free DNA Methylation Markers for Hepatocellular Carcinoma

Recruiting
  • Cell-free Methylation Markers
    • Taipei, Taiwan, Taiwan
      National Taiwan University Hospital
    Oct 6, 2022

    Burning Mouth Syndrome Trial in Napoli (Vortioxetine 20Mg Tab, Paroxetine 20 Mg Oral Tablet, Sertraline 50 MG)

    Recruiting
    • Burning Mouth Syndrome
    • Vortioxetine 20Mg Tab
    • +6 more
    • Napoli, Italia, Italy
      University of Naples Federico II
    Aug 29, 2023

    Breast Cancer Trial in Angers, Saint-Herblain (Biopsy, Blood samples, Questionnaires)

    Not yet recruiting
    • Breast Cancer
    • Biopsy
    • +2 more
    • Angers, France
    • +1 more
    Jul 31, 2023

    REsponse to Depression Interventions Using Clinical and TD-fNIRS

    Enrolling by invitation
    • Depression
    • Major Depressive Disorder
    • fNIRS measurement
    • La Jolla, California
    • +2 more
    Aug 17, 2023

    tDCS Response Prediction Using EEG in Stroke

    Recruiting
    • Stroke
    • +3 more
    • Cathodal transcranial direct current stimulation (tDCS) over the contralesional motor cortex
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +1 more
    May 15, 2022

    Pharmacogenetic Testing and Chronic Pain

    Not yet recruiting
    • Chronic Pain
    • Genetic test for drug response prediction
    • Ottawa, Ontario, Canada
      Canadian Forces Health Services Centre
    Apr 28, 2022

    Prediction of Adolescents With MDD Response to ECT Via MRI

    Recruiting
    • Major Depressive Disorder
    • +2 more
    • Modified Electroconvulsive Therapy
    • Conventional pharmacotherapy
    • Chongqing, Province, China
      The First Affiliated Hospital of Chongqing Medical University
    May 26, 2023

    Depressive Disorder Trial in Utrecht (Rivastigmine Transdermal Product, Sham)

    Recruiting
    • Depressive Disorder
    • Rivastigmine Transdermal Product
    • Sham
    • Utrecht, Netherlands
      UMC Utrecht
    Mar 2, 2023

    Prediction of Methotrexate Response - A Pilot Study

    Completed
    • Rheumatoid Arthritis
    • Rheumatic Diseases
      • Concord, North Carolina
        Carolinas Medical Center - NorthEast
      Aug 31, 2022

      ADHD Trial in Boston (MRI)

      Active, not recruiting
      • Attention Deficit Hyperactivity Disorder
      • MRI
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 22, 2022

      Computation Prediction of Drug Response Based on Omics Data

      Enrolling by invitation
      • Breast Cancer
      • virtual anti-cancer drug
      • Beijing, Beijing, China
        Shuhua Zhao
      Apr 25, 2023

      Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer

      Recruiting
      • Non-small Cell Lung Cancer
        • Lille, France
        • +3 more
        Jan 25, 2023

        Oral Cavity Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab)

        Active, not recruiting
        • Oral Cavity Squamous Cell Carcinoma
        • Amsterdam, Noord-Holland, Netherlands
          VU University medical center
        Oct 6, 2021

        System of mCRC Patients Based on CTC

        Not yet recruiting
        • Colorectal Cancer Stage IV
        • Circulating Tumor Cell
        • Circulating tumor cell
        • (no location specified)
        Jun 2, 2021

        Treatment (PROMPT) Response (PROMPT)

        Recruiting
        • Major Depressive Disorder
        • Münster, Germany
          Bernhard Baune
        Sep 12, 2022

        Liver and Biliary Cancer Patients Treated With PD-1 Combination

        Active, not recruiting
        • Hepatocellular Carcinoma
        • Bile Duct Cancer
        • [68Ga]FAPI PET/CT and [18F]FDG PET/CT
        • Beijing, China
          Department of Nuclear Medicine, Peking Union Medical College Hop
        Dec 14, 2022

        Predict the Response of Biliary Tract Tumors to Immunotherapy

        Recruiting
        • Biliary Tract Tumor
        • Cholangiocarcinoma
        • Blood samples, tumor biopsy specimens will be collected
        • Hangzhou, Zhejiang, China
          Zhejiang Cancer Hospital
        Sep 22, 2023